Literature DB >> 24686738

Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Taher Uddin1, Amena Aktar, Peng Xu, Russell A Johnson, M Arifur Rahman, Daniel T Leung, Sadia Afrin, Aklima Akter, Mohammad Murshid Alam, Atiqur Rahman, Fahima Chowdhury, Ashraful I Khan, Taufiqur Rahman Bhuiyan, Meagan K Bufano, Rasheduzzaman Rashu, Yanan Yu, Ying Wu-Freeman, Jason B Harris, Regina C LaRocque, Richelle C Charles, Pavol Kováč, Stephen B Calderwood, Edward T Ryan, Firdausi Qadri.   

Abstract

Protective immunity to cholera is serogroup specific, and serogrouping is defined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). We characterized OSP-specific immune responses in adult recipients of an oral killed cholera vaccine (OCV WC-rBS) and compared these with responses in patients with cholera caused by Vibrio cholerae O1 Ogawa. Although vaccinees developed plasma immunoglobulin G (IgG), IgM, IgA antibody and antibody secreting cell (ASC, marker of mucosal response) to Ogawa OSP and LPS 7 days after vaccination, responses were significantly lower than that which occurred after cholera. Similarly, patients recovering from cholera had detectable IgA, IgM, and IgG memory B cell (MBC) responses against OSP and LPS on Day 30 and Day 90, whereas vaccinees only developed IgG responses to OSP 30 days after the second immunization. The markedly lower ASC and MBC responses to OSP and LPS observed among vaccinees might explain, in part, the lower protection of an OCV compared with natural infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686738      PMCID: PMC4015581          DOI: 10.4269/ajtmh.13-0498

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  49 in total

1.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

3.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

4.  Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.

Authors:  Suman Kanungo; Allison Paisley; Anna Lena Lopez; Mihir Bhattacharya; Byomkesh Manna; Deok Ryun Kim; Seung Hyun Han; Stephen Attridge; Rodney Carbis; Raman Rao; Jan Holmgren; John D Clemens; Dipika Sur
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

5.  Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

Authors:  Amit Saha; Mohiul Islam Chowdhury; Farhana Khanam; Md Saruar Bhuiyan; Fahima Chowdhury; Ashraful Islam Khan; Iqbal Ansary Khan; John Clemens; Mohammad Ali; Alejandro Cravioto; Firdausi Qadri
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

6.  Natural cholera infection-derived immunity in an endemic setting.

Authors:  Mohammad Ali; Michael Emch; Jin Kyung Park; Mohammad Yunus; John Clemens
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

7.  Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139.

Authors:  Firdausi Qadri; Rubhana Raqib; Firoz Ahmed; Taufiqur Rahman; Christine Wenneras; Swadesh Kumar Das; Nur Haque Alam; Minnie M Mathan; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

8.  Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines.

Authors:  Peng Xu; Mohammad Murshid Alam; Anuj Kalsy; Richelle C Charles; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Bioconjug Chem       Date:  2011-09-30       Impact factor: 4.774

9.  Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Authors:  Debasish Saha; Regina C LaRocque; Ashraful I Khan; Jason B Harris; Yasmin Ara Begum; Syed M Akramuzzaman; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

10.  Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Authors:  Dipika Sur; Suman Kanungo; Binod Sah; Byomkesh Manna; Mohammad Ali; Allison M Paisley; Swapan K Niyogi; Jin Kyung Park; Banawarilal Sarkar; Mahesh K Puri; Deok Ryun Kim; Jacqueline L Deen; Jan Holmgren; Rodney Carbis; Raman Rao; Thu Van Nguyen; Seung Hyun Han; Stephen Attridge; Allan Donner; Nirmal K Ganguly; Sujit K Bhattacharya; G Balakrish Nair; John D Clemens; Anna Lena Lopez
Journal:  PLoS Negl Trop Dis       Date:  2011-10-18
View more
  19 in total

1.  Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection.

Authors:  Louise C Ivers; Richelle C Charles; Isabelle J Hilaire; Leslie M Mayo-Smith; Jessica E Teng; J Gregory Jerome; Jenna Rychert; Regina C LaRocque; Peng Xu; Pavol Kovácˇ; Edward T Ryan; Firdausi Qadri; Charles P Almazor; Molly F Franke; Jason B Harris
Journal:  J Infect Dis       Date:  2015-02-26       Impact factor: 5.226

2.  A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.

Authors:  Kara J Levinson; Danielle E Baranova; Nicholas J Mantis
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

Review 3.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

4.  O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Authors:  Amena Aktar; M Arifur Rahman; Sadia Afrin; M Omar Faruk; Taher Uddin; Aklima Akter; M Israk Nur Sami; Tahirah Yasmin; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Regina C LaRocque; Richelle C Charles; Taufiqur Rahman Bhuiyan; Anjali Mandlik; Meagan Kelly; Pavol Kováč; Peng Xu; Stephen B Calderwood; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

5.  Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.

Authors:  Wilfredo R Matias; Brie Falkard; Richelle C Charles; Leslie M Mayo-Smith; Jessica E Teng; Peng Xu; Pavol Kováč; Edward T Ryan; Firdausi Qadri; Molly F Franke; Louise C Ivers; Jason B Harris
Journal:  PLoS Negl Trop Dis       Date:  2016-06-16

6.  Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.

Authors:  Robert C Kauffman; Taufiqur R Bhuiyan; Rie Nakajima; Leslie M Mayo-Smith; Rasheduzzaman Rashu; Mohammad Rubel Hoq; Fahima Chowdhury; Ashraful Islam Khan; Atiqur Rahman; Siddhartha K Bhaumik; Levelle Harris; Justin T O'Neal; Jessica F Trost; Nur Haq Alam; Algis Jasinskas; Emmanuel Dotsey; Meagan Kelly; Richelle C Charles; Peng Xu; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Phillip L Felgner; Firdausi Qadri; Jens Wrammert; Jason B Harris
Journal:  mBio       Date:  2016-12-20       Impact factor: 7.867

7.  Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.

Authors:  Muhammad Ikhtear Uddin; Shahidul Islam; Naoshin S Nishat; Motaher Hossain; Tanzeem Ahmed Rafique; Rasheduzzaman Rashu; Mohammad Rubel Hoq; Yue Zhang; Amit Saha; Jason B Harris; Stephen B Calderwood; Taufiqur Rahman Bhuiyan; Edward T Ryan; Daniel T Leung; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2016-11-08

8.  Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh.

Authors:  Richelle C Charles; Rie Nakajima; Li Liang; Al Jasinskas; Amanda Berger; Daniel T Leung; Meagan Kelly; Peng Xu; Pavol Kovác; Samantha R Giffen; James D Harbison; Fahima Chowdhury; Ashraful I Khan; Stephen B Calderwood; Taufiqur Rahman Bhuiyan; Jason B Harris; Philip L Felgner; Firdausi Qadri; Edward T Ryan
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

9.  Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Authors:  Kamrul Islam; Motaher Hossain; Meagan Kelly; Leslie M Mayo Smith; Richelle C Charles; Taufiqur Rahman Bhuiyan; Pavol Kováč; Peng Xu; Regina C LaRocque; Stephen B Calderwood; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2018-04-06

10.  Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.

Authors:  Amena Aktar; M Arifur Rahman; Sadia Afrin; Aklima Akter; Taher Uddin; Tahirah Yasmin; Md Israk Nur Sami; Pinki Dash; Sultana Rownok Jahan; Fahima Chowdhury; Ashraful I Khan; Regina C LaRocque; Richelle C Charles; Taufiqur Rahman Bhuiyan; Anjali Mandlik; Meagan Kelly; Pavol Kováč; Peng Xu; Stephen B Calderwood; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.